​
​

Amneal Pharmaceuticals (AMRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Amneal Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$2.39B

Latest Revenue (Q)

$702.47M

Main Segment (Y)

Generics Segment

Main Geography (Y)

Generics Segment

Amneal Pharmaceuticals Revenue by Period

Amneal Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-8.20%
2022-12-31-5.67%
2021-12-31-5.08%
2020-12-31-22.51%
2019-12-31--2.20%
2018-12-31-60.88%
2017-12-31-1.52%
2016-12-31--

Amneal Pharmaceuticals generated $2.39B in revenue during NA 2023, up 8.20% compared to the previous quarter, and up 143.93% compared to the same period a year ago.

Amneal Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-0.10%
2024-06-30-6.46%
2024-03-31-6.84%
2023-12-31--0.49%
2023-09-30-3.50%
2023-06-30-7.44%
2023-03-31--8.56%
2022-12-31-11.77%
2022-09-30--2.47%
2022-06-30-12.40%
2022-03-31--7.31%
2021-12-31-1.57%
2021-09-30--1.21%
2021-06-30-8.51%
2021-03-31--3.32%
2020-12-31--1.78%
2020-09-30-11.76%
2020-06-30--6.79%
2020-03-31-25.47%
2019-12-31-5.03%
2019-09-30--6.51%
2019-06-30--9.30%
2019-03-31--10.33%
2018-12-31-4.42%
2018-09-30-15.15%
2018-06-30-50.36%
2018-03-31--6.20%
2017-12-31-15.17%
2017-09-30--1.98%
2017-06-30-15.15%
2017-03-31--24.41%
2016-12-31--

Amneal Pharmaceuticals generated $702.47M in revenue during Q3 2024, up 0.10% compared to the previous quarter, and up 117.26% compared to the same period a year ago.

Amneal Pharmaceuticals Revenue Breakdown

Amneal Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Specialty Segment-----
Generics Segment-----
Amneal Specialty Pharma Segment-----
Av K A R E Segment-----
Av Kare-----

Amneal Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Generics Segment (79.03%), and Specialty Segment (20.97%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Generics Segment--------------------
Amneal Specialty Pharma Segment--------------------
Av K A R E Segment--------------------
Specialty Segment--------------------
Rytary Family--------------------
Oxymorphone--------------------
Levothyroxine Sodium--------------------
Epinephrine Auto Injector Family Generic Adrenaclick--------------------
Diclofenac Sodium Gel--------------------
Yuvafem-Estradiol--------------------
Epinephrine Auto-Injector Family (Generic Adrenaclick)--------------------

Amneal Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Generics Segment (78.70%), and Amneal Specialty Pharma Segment (21.30%).

Amneal Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Generics Segment-----
Specialty Segment-----

Amneal Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: Generics Segment (79.03%), and Specialty Segment (20.97%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Generics Segment--------------------
Specialty Segment--------------------

Amneal Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 24: Generics Segment (78.70%), and Specialty Segment (21.30%).

Amneal Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMRXAmneal Pharmaceuticals--
NBIXNeurocrine Biosciences--
ALKSAlkermes--
PAHCPhibro Animal Health--
AMPHAmphastar Pharmaceuticals--
COLLCollegium Pharmaceutical--
ANIPANI Pharmaceuticals--
ITCIIntra-Cellular Therapies--
IRWDIronwood Pharmaceuticals--
PROCProcaps Group--
EGRXEagle Pharmaceuticals--
DVAXDynavax--
EOLSEvolus--
DCPHDeciphera Pharmaceuticals--
ASRTAssertio--
LFCRLifecore Biomedical--
AGRXAgile Therapeutics--
SSICSilver Spike Investment--
ACRXTalphera--

AMRX Revenue FAQ

What is Amneal Pharmaceuticals’s yearly revenue?

Amneal Pharmaceuticals's yearly revenue for 2023 was $2.39B, representing an increase of 8.20% compared to 2022. The company's yearly revenue for 2022 was $2.21B, representing an increase of 5.67% compared to 2021. AMRX's yearly revenue for 2021 was $2.09B, representing an increase of 5.08% compared to 2020.

What is Amneal Pharmaceuticals’s quarterly revenue?

Amneal Pharmaceuticals's quarterly revenue for Q3 2024 was $702.47M, a 0.10% increase from the previous quarter (Q2 2024), and a 13.29% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $701.78M, a 6.46% increase from the previous quarter (Q1 2024), and a 17.15% increase year-over-year (Q2 2023). AMRX's quarterly revenue for Q1 2024 was $659.19M, a 6.84% increase from the previous quarter (Q4 2023), and a 18.23% increase year-over-year (Q1 2023).

What is Amneal Pharmaceuticals’s revenue growth rate?

Amneal Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 14.33%, and for the last 5 years (2019-2023) was 47.17%.

What are Amneal Pharmaceuticals’s revenue streams?

Amneal Pharmaceuticals's revenue streams in c 23 are Specialty Segment, and Generics Segment. Specialty Segment generated $390.46M in revenue, accounting 20.97% of the company's total revenue, up 22.97% year-over-year. Generics Segment generated $1.47B in revenue, accounting 79.03% of the company's total revenue, up 2.75% year-over-year.

What is Amneal Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Amneal Pharmaceuticals was Generics Segment. This segment made a revenue of $1.47B, representing 79.03% of the company's total revenue.